Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population
Information source: Phoenix Children's Hospital
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Disorder of Urinary Stent
Intervention: Tamsulosin (Drug); Oxybutynin (Drug)
Phase: N/A
Status: Not yet recruiting
Sponsored by: Phoenix Children's Hospital Overall contact: Michael Nguyen, MD, Phone: (602) 933-5200, Email: mtn1023@hotmail.com
Summary
The primary objective of this study is to evaluate the efficacy and safety tamsulosin in
reducing stent discomfort in the pediatric population in the peri-operative period. The
secondary objective is to compare the efficacy of tamsulosin with that of oxybutynin in
reducing stent discomfort.
Clinical Details
Official title: Randomized Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Discomfort in the Pediatric Population
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: Number of doses of pain in medication usedPain scale based on the faces pain score
Eligibility
Minimum age: 4 Years.
Maximum age: 18 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients aged 4-18 years will be enrolled in this study. We will include all patients
who will have a ureteral stent placement after their procedure.
Exclusion Criteria:
- Patients with developmental delay or unable to verbalize their pain level will be
excluded.
Locations and Contacts
Michael Nguyen, MD, Phone: (602) 933-5200, Email: mtn1023@hotmail.com Additional Information
Starting date: July 2015
Last updated: June 26, 2015
|